Jeffrey Stein - 23 May 2016 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: President & CEO, Director
Signature: /s/ Shane Ward, Attorney-in-Fact
Issuer symbol: CDTX
Transactions as of: 23 May 2016
Net transactions value: $0
Form type: 4
Filing time: 07 Jan 2026, 20:12:25 UTC
Next filing: 16 Jun 2021
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Stein Jeffrey	President & CEO, Director	6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO	/s/ Shane Ward, Attorney-in-Fact	07 Jan 2026	0001478831

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Other		-270	-2.6%		10,025	23 May 2016	Direct	F1, F2
transaction	CDTX	Common Stock	Other	$99,975	-645	-6.4%	$155.00	9,380	31 Mar 2017	Direct	F2, F3
transaction	CDTX	Common Stock	Purchase	$99,975	+645	+0.99%	$155.00^*	65,754	31 Mar 2017	By trust	F2, F3
transaction	CDTX	Common Stock	Other	$89,211	-750	-8%	$118.95	8,630	05 Jun 2017	Direct	F2, F4
transaction	CDTX	Common Stock	Purchase	$89,211	+750	+1.1%	$118.95^*	66,504	05 Jun 2017	By trust	F2, F4
transaction	CDTX	Common Stock	Other	$49,839	-367	-4.3%	$135.80	8,263	12 Sep 2017	Direct	F2, F5
transaction	CDTX	Common Stock	Purchase	$49,839	+367	+0.55%	$135.80^*	66,871	12 Sep 2017	By trust	F2, F5
transaction	CDTX	Common Stock	Other	$100,015	-2,500	-30%	$40.01	5,763	10 Nov 2020	Direct	F2, F6
transaction	CDTX	Common Stock	Purchase	$100,015	+2,500	+3.7%	$40.01^*	69,371	10 Nov 2020	By trust	F2, F6
transaction	CDTX	Common Stock	Other	$0	-658	-31%	$0.000000	1,442	10 Dec 2020	By son	F2, F7
transaction	CDTX	Common Stock	Gift	$0	-1,873	-2.7%	$0.000000	67,498	31 Dec 2021	By trust	F2, F8
transaction	CDTX	Common Stock	Gift	$0	+937	+65%	$0.000000	2,379	31 Dec 2021	By son	F2, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Form 4 originally filed on May 23, 2016 erroneously overstated the Amount of Securities Beneficially Owned by Reporting Person.
F2	The number of securities and price reported herein have been adjusted to reflect the 1-for-20 reverse stock split effected by the Issuer on April 24, 2024.
F3	Form 4 originally filed on April 4, 2017 erroneously reported the securities as purchased by Reporting Person rather than by trust.
F4	Form 4 originally filed on June 7, 2017 erroneously reported the securities as purchased by Reporting Person rather than by trust.
F5	Form 4 originally filed on September 12, 2017 erroneously reported the securities as purchased by Reporting Person rather than by trust.
F6	Form 4 originally filed on November 10, 2020 erroneously reported the securities as purchased by Reporting Person rather than by trust.
F7	Form 4 originally filed on March 19, 2021 erroneously reported a 26,300 share gift as a holding rather than a transaction and further overstated the holdings received by son by 13,150 shares.
F8	This transaction involved a gift of securities by the Reporting Person to his sons, one of which is economically dependent on the Reporting Person. The Reporting Person disclaims beneficial ownership of the shares held by his independent son, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his independent son's shares for purposes of Section 16 or for any other purpose.